Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Neal Katz
Director of Solutions Marketing
Connect with Neal Katz on LinkedIn
Website: http://www.elsevier.com
About the author:
Neal Katz has over 20 years of experience bringing information technology solutions to market. As Senior Manager of Solutions Marketing at Elsevier, Neal has been responsible for assembling information solutions for life science companies, as well as academic and government institutions. He has developed similar solutions and programs at companies like AT&T and Intel.
Posts by Neal Katz
Taking a Balanced Approach to Monitoring Literature
Posted on September 11th, 2017 in Pharmacovigilance
In a time when the focus on pharmacovigilance is greater than ever before, literature monitoring presents pharmaceutical companies with significant challenges. Pharmacovigilance groups are looking for ways to efficiently and cost-effectively manage an increasing workload while remaining compliant with regulatory best practices. Continue reading “Taking a Balanced Approach to Monitoring Literature” »
Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events
Posted on August 21st, 2017 in Pharma R&D
High-quality compound bioactivity data and information about biological pathways and potential drug targets is more readily available than ever—and in enormous amounts that are often daunting to researchers Continue reading “Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events” »
Creating a Formula for Precise, Effective Literature Searching
Posted on July 31st, 2017 in Pharmacovigilance
Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. Continue reading “Creating a Formula for Precise, Effective Literature Searching” »
Compliant Monitoring of Adverse Events
Posted on May 24th, 2017 in Pharmacovigilance
Developing and maintaining a solid strategy for screening for adverse events is critical for every pharmaceutical company. Without one, an adverse event could be reported in scientific literature without the company knowing — and failure to report it to the regulatory authorities could result in a serious warning. Continue reading “Compliant Monitoring of Adverse Events” »
